About the Webinar
Widely prescribed over decades to treat a bladder condition called interstitial cystitis, Elmiron is now linked to maculopathy and other life-altering eye injuries. It is estimated that hundreds of thousands of people have taken the drug -- the majority of whom are women.
As firms across the country work to sign Elmiron clients, SimplyConvert and Pattern Data are teaming up for a 45-minute webinar on Thursday, April 29th at 2 pm ET that you won't want to miss.
From Intake to Evidence: Elmiron Eye Injury Litigation will include insights on the litigation from leading members of the Plaintiff's Steering Committee and will spotlight how firms can use forward-thinking technology to build stronger case inventories.
Panelists will discuss the following:
- Elmiron litigation update and next steps
- Science overview and injury profiles
- Using AI to analyze medical data and identify case trends sooner
- AI-powered client intake and evidence-driven refinements to case selection criteria
Space is limited. Register today!